Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
August 1, 2017
Ocera Therapeutics Reports Second Quarter 2017 Financial Results
REDWOOD CITY, Calif. and RESEARCH TRIANGLE PARK, N.C., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Ocera Therapeutics, Inc. (OCRX), a clinical stage biopharmaceutical company focused on ...
August 1, 2017
TRACON to Report Second Quarter Company Highlights and Financial Results on August 8, 2017
SAN DIEGO, Aug. 01, 2017 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
August 1, 2017
Prothena to Report Second Quarter 2017 Financial Results on August 8
DUBLIN, Ireland, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Prothena Corporation plc (PRTA), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of ...
August 1, 2017
DURECT Corporation Invites You to Join its Second Quarter 2017 Earnings Conference Call
CUPERTINO, Calif., Aug. 1, 2017 /PRNewswire/ -- In conjunction with DURECT Corporation's (DRRX) second quarter 2017 financial results press release, you are invited to listen to ...
August 1, 2017
Gemphire Therapeutics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
LIVONIA, Mich., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (GEMP), today announced that on July 31, 2017, the Compensation Committee of its Board ...
August 1, 2017
Zealand Pharma A/S commences initial public offering of American Depositary Shares in the United States
Copenhagen, August 1, 2017 - With reference to the company announcement no. 25/2017, dated July 6, 2017, regarding the initial public filing of registration statement ...
August 1, 2017
Kamada Reports Financial Results for Second Quarter and First Six Months of 2017
REHOVOT, Israel, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (KMDA) (KMDA), a plasma-derived protein therapeutics company focused on orphan indications, today announced financial results ...
August 1, 2017
CytoSorbents to Report Q2 2017 Operating and Financial Results
MONMOUTH JUNCTION, N.J., Aug. 1, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO),  CytoSorbents Corporation (CTSO), a critical care immunotherapy leader commercializing its CytoSorb® blood purification technology to treat deadly inflammation ...
August 1, 2017
Mateon Therapeutics Completes Enrollment in Phase 2 Portion of FOCUS Study of CA4P for Platinum-Resistant Ovarian Cancer
SOUTH SAN FRANCISCO, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment ...
August 1, 2017
iCAD to Present at the Canaccord Genuity 37th Annual Growth Conference
NASHUA, N.H., Aug. 01, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the ...
August 1, 2017
Zogenix to Release Second Quarter 2017 Financial Results and Host Conference Call and Webcast on August 8
EMERYVILLE, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Zogenix, Inc. (ZGNX), a pharmaceutical company developing therapies for the treatment of orphan and central nervous system ...
August 1, 2017
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
BOSTON, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (PRTK), a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon ...
August 1, 2017
Threshold Pharmaceuticals Announces Results of Annual Meeting of Stockholders
MENLO PARK, Calif., Aug. 01, 2017 (GLOBE NEWSWIRE) -- Threshold Pharmaceuticals, Inc. (THLD) announced today that its stockholders approved all of the proposals presented at ...
August 1, 2017
Reata Pharmaceuticals, Inc. Announces Closing of Class A Common Stock Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
IRVING, Texas, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA) (“Reata” or the “Company”), a clinical-stage biopharmaceutical company, today announced the closing of ...
August 1, 2017
VALNEVA Announces Expansion of its Management Board - Strengthening Senior Management for Future Growth
Lyon (France), August 1, 2017 - Valneva SE ("Valneva" or "the Company"), a fully integrated commercial stage biotech company focused on developing innovative, lifesaving vaccines, ...
August 1, 2017
20 Executives Selected for Women In Bio’s Second Boardroom Ready Class: Preparing Women in Life Sciences for Boards of Directors Roles
BOSTON, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Gender equality momentum continues, as an additional 20 accomplished female life sciences executives will comprise the second cohort ...
July 31, 2017
Transgene: First Patient Dosed in a Phase 1/2 Trial of Pexa-Vec + Opdivo® for the First-Line Treatment of Advanced Liver Cancer
Transgene (TNG.PA), a company that designs and develops viral-based immunotherapies, today announces that the first patient has been treated in a Phase 1/2 clinical trial evaluating ...
July 31, 2017
Onxeo Divests Two Non-Core Products in Oral Pathologies to Vectans Pharma
Onxeo S.A. (ONXEO.PA) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ Copenhagen: ONXEO), (“Onxeo” or the “Company”), a clinical-stage biotechnology company specializing in the development of innovative drugs ...
July 31, 2017
Kitov Submits New Drug Application to FDA for KIT-302
TEL AVIV, Israel, July 31, 2017 /PRNewswire/ -- Kitov Pharmaceuticals Holdings Ltd. (NASDAQ: KTOV, TASE: KTOV), an innovative biopharmaceutical company, today announced that it has submitted ...
July 31, 2017
ADMA Biologics Strengthens Patent Portfolio Through Newly Issued U.S. Patent for Immunotherapeutic Methods
RAMSEY, N.J. and BOCA RATON, Fla., July 31, 2017 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (ADMA) is a vertically integrated biopharmaceutical and specialty immunoglobulin  company ...
Page 123 of 138